What is Esperion Therapeutics's shares (basic)?

Esperion Therapeutics (ESPR) reported shares (basic) of 251.4M in Q1 2026.

How has Esperion Therapeutics's shares (basic) changed year-over-year?

Esperion Therapeutics's shares (basic) increased by 28.2% year-over-year, from 196.1M to 251.4M.

What is the long-term trend for Esperion Therapeutics's shares (basic)?

Over 4 years (2021 to 2025), Esperion Therapeutics's shares (basic) has grown at a 65.3% compound annual growth rate (CAGR), from 107.6M to 802.3M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Esperion Therapeutics ESPR Shares (Basic)

Shares (Basic) at other companies

AmgenAMGN

540M+0.4%

Regeneron PharmaceuticalsREGN

104M-2.5%

Lexicon PharmaceuticalsLXRX

400.2M+10.5%

Zevra Therapeutics, Inc.ZVRA

58.4M+8.0%

Eton Pharmaceuticals, Inc.ETON

27.3M+1.5%

Nurix Therapeutics, Inc.NRIX

110.1M+31.7%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's shares (basic)?: Esperion Therapeutics (ESPR) reported shares (basic) of 251.4M in Q1 2026.
How has Esperion Therapeutics's shares (basic) changed year-over-year?: Esperion Therapeutics's shares (basic) increased by 28.2% year-over-year, from 196.1M to 251.4M.
What is the long-term trend for Esperion Therapeutics's shares (basic)?: Over 4 years (2021 to 2025), Esperion Therapeutics's shares (basic) has grown at a 65.3% compound annual growth rate (CAGR), from 107.6M to 802.3M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.